Biomerica, Inc. (BMRA) Cleared to List on Nasdaq CM

August 24, 2016 8:19 AM EDT

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

Biomerica Inc. (OTC: BMRA) (Nasdaq: BMRA) announced that its common stock has been approved for listing on the Nasdaq Capital Market and is expected to commence trading on Nasdaq under the ticker symbol "BMRA" on August 26, 2016. The Company's common stock will continue to trade as "BMRA" on the OTCQB until the market close on August 25, 2016.

"Uplisting to Nasdaq represents a milestone for Biomerica as we continue our progress in the commercialization of our new IBS diagnostic guided therapy product," said Zackary Irani, CEO of Biomerica. "Trading on the Nasdaq Capital Market will increase our visibility and enhance Biomerica's corporate profile, providing us access to a broader investor base that we believe will ultimately lead to improved liquidity for shareholders."

Biomerica's executive team believes the transition to Nasdaq may qualify the Company's common stock to be traded by more mutual funds, pension funds, and other institutional holders.

Nasdaq is home to more than 3,400 listed companies with a market value of over $8.5 trillion.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Hot Corp. News

Add Your Comment